SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 80 filers reported holding SAVARA INC in Q4 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,882,000 | +7.2% | 710,310 | -4.2% | 0.32% | +54.8% |
| Q2 2019 | $1,756,000 | -73.4% | 741,100 | -17.3% | 0.21% | -73.6% |
| Q1 2019 | $6,605,000 | +3.1% | 896,200 | +5.9% | 0.79% | -8.8% |
| Q4 2018 | $6,408,000 | -28.8% | 846,500 | +5.0% | 0.87% | -8.9% |
| Q3 2018 | $9,001,000 | +139.8% | 806,500 | +143.3% | 0.96% | +127.6% |
| Q2 2018 | $3,753,000 | +49.4% | 331,500 | +21.4% | 0.42% | +52.7% |
| Q1 2018 | $2,512,000 | +5.8% | 273,000 | +70.6% | 0.28% | -7.4% |
| Q4 2017 | $2,374,000 | – | 160,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
| NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
| Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
| TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
| VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
| Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
| Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
| Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
| Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
| Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |